| Name | levonorgestrel |
|---|---|
| Synonyms |
Mirena
Norgestrel RS 18,19-Dinor-17-alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (+-) (±) Di-Norgestrel 18-Methyl-17a-ethynyl-19-nortestosterone (−)-Norgestrel dl-13b-ethyl-17a-ethynyl-17b-hydroxygon-4-en-3-one Norplant 13-ethyl-17-hydroxy-19-dinorpregn-4-en-20-yn-3-on(17-alpha)-(+-)-1 Levonelle Norgestrel //BP 13-β-ETHYL-17-α-ETHYNYL-17-β-HYDROXYGON-4-EN-3-ONE MFCD01546387 NORPLANT Norgestrel (DL-) (+/-)-NORGESTREL-D6 wy3707 17b-Hydroxy-18-methyl-19-nor-17a-pregn-4-en-20-yn-3-one (+-)-17a-Ethynyl-13b-ethylgon-4-en-17b-ol-3-one (8R,9S,10R,13S,14S,17R)-17-Ethinyl-13-ethyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-on 13BETA-ETHYL-17ALPHA-ETHYNYL-17BETA-HYDROXYGON-4-EN-3-ONE LEVONORGESTRAL 13-Ethyl-17a-ethynyl-17b-hydroxy-4-gonen-3-one Levonorgestrel-D6 sh70850 4-PREGNEN-13BETA-ETHYL-18,19-DINOR 17BETA-OL-3-ONE-20-YNE NORGESTREL(LEVO) 17a-Ethynyl-18-methyl-19-nortestosterone 17a-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one Norgestrel Steroids Powders 18,19-DINOR-4-PREGNEN-20-YN-3-ONE 13-Ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one 17a-Ethynyl-13-ethyl-19-nortestosterone dl-norgestrel (+-)-17a-Ethynyl-13-ethyl-17-hydroxygon-4-en-3-one Levonorgestrel-d6((-)-Norgestrel-2,2,4,6,6,10-d6) NorLevo (+-)-13-ethyl-17-hydroxy-18,19-dinor-17-alpha-pregn-4-en-20-yn-3-one (17α)-(+/-)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one (17a)-(-)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one (17a)-(-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one 13-Ethyl-17a-ethynyl-17-hydroxygon-4-en-3-one fh122-a (8R,9S,10R,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one 13-Ethyl-17-ethynyl-17b-hydroxy-4-gonen-3-one (+/-)-13-ETHYL-17ALPHA-HYDROXY-18,19-DINORPREGN-4-EN-20-YN-3-ONE 17a-Ethynyl-18-homo-19-nortestosterone Norgeston Methylnorethindrone dl-11b-Ethyl-17a-ethynyl-17b-hydroxygon-4-en-3-one monov 13b-Ethyl-17a-ethynyl-17b-hydroxygon-4-en-3-one 18-METHYLNORETHINDRONE 4-ESTREN-17-ALPHA-ETHYNYL-18-HOMO-17-BETA-OL-3-ONE(+/-) a-Norgestrel ldnorgestrel 17-ALPHA-ETHYNYL-18-HOMO-19-NORTESTOSTERONE (17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one 13-beta-ethyl-17-beta-hydroxy-18,19-dinor-17-alpha-pregn-4-en-20-yn-3-one 4-GONEN-13BETA-ETHYL-17ALPHA-ETHYNYL-17BETA-OL-3-ONE Norgestrel Solution, 100ppm monovar OVRETTE(R) 18-Methyl Norgestrel Novogestrel sh850 (+-)-13-Ethyl-17a-ethynyl-17-hydroxygon-4-en-3-one rac-(13R*)-13-Ethyl-17α-hydroxy-18,19-dinorpregna-4-ene-20-yne-3-one 18,19-Dinor-17a-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (+-)- (8CI) Levonova D-NORGESTREL Norgestrel IP (8R,9S,10R,13S,14S,17R)-13-éthyl-17-éthynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tétradécahydro-3H-cyclopenta[a]phénanthrén-3-one dl-13-beta-ethyl-17-alpha-ethynyl-19-nortestosterone EINECS 212-349-8 Norgestrel CRS D-Norgestrel Microval 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17a)-(+-)- (9CI) Norgestrel Microlut Ovrette dl-13-beta-ethyl-17-alpha-ethynyl-17-beta-hydroxygon-4-en-3-one UNII:3J8Q1747Z2 D(−)-Norgestrel D(-)-NORGESTREL NORGESTREL alpha-norgestrel D-(-)-Norgestrel Neogest (-)-Norgestrel 18,19-DINOR-13-BETA-ETHYL-17-BETA-HYDROXY-4-PREGNEN-20-YN-3-ONE |
| Description | Norgestrel is a synthetic analog of progesterone, a compound commonly found in oral contraceptive pill, and a powerful neuroprotective antioxidant, preventing light-induced ROS in photoreceptor cells, and cell death[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Norgestrel (20 µM; 24 hours; 661W cells) treatment significantly increases cellular viability after serum deprivation and so it is demonstrated that Norgestrel is neuroprotective to stressed 661W cells[1]. Norgestrel (20 µM; 24 hours; 661W cells) treatment decreases apoptotic induced cleavage of PARP and caspase-3[1]. Norgestrel (20 µM; 6 hours; 661W cells) treatment bFGF is results in a significant upregulation of bFGF mRNA in photoreceptor cells[1]. Cell Viability Assay[1] Cell Line: 661W cells Concentration: 20 µM Incubation Time: 24 hours Result: Significantly increased cellular viability after serum deprivation. Western Blot Analysis[1] Cell Line: 661W cells Concentration: 20 µM Incubation Time: 24 hours Result: Decreased apoptotic induced cleavage of PARP and caspase-3. RT-PCR[1] Cell Line: 661W cells Concentration: 20 µM Incubation Time: 6 hours Result: A significant upregulation of bFGF mRNA over 1 hour. |
| In Vivo | Norgestrel (100 mg/kg; intraperitoneal injection; for 6, 24 or 48 hours; Balb/c mice) treatment can prevent light-induced ROS in photoreceptor cells, and subsequent cell death. Norgestrel acts via post-translational modulation of the major antioxidant transcription factor Nrf2; bringing about its phosphorylation, subsequent nuclear translocation, and increases levels of its effector protein superoxide dismutase 2 (SOD2)[2]. Animal Model: Balb/c mice are born into and maintained in dim cyclic light[2] Dosage: 100 mg/kg; Administration: Intraperitoneal injection; for 6, 24 or 48 hours Result: Increased expression and activation of Nrf2 via phosphorylation on serine 40, increased expression of its target antioxidant superoxide dismutase 2 (SOD2), and reduced mitochondrial oxidative stress. |
| References |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 459.1±45.0 °C at 760 mmHg |
| Melting Point | 239-241ºC |
| Molecular Formula | C21H28O2 |
| Molecular Weight | 312.446 |
| Flash Point | 195.4±21.3 °C |
| Exact Mass | 312.208923 |
| PSA | 37.30000 |
| LogP | 3.92 |
| Vapour Pressure | 0.0±2.6 mmHg at 25°C |
| Index of Refraction | 1.571 |
| Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Hazard Codes | Xn:Harmful |
|---|---|
| Risk Phrases | R20/21/22;R40 |
| Safety Phrases | S22-S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | JF8259000 |